Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD.

MLA

Ellis, Paul, et al. “Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD.” International Journal of COPD, vol. 19, Jan. 2024, pp. 149–59. EBSCOhost, https://doi.org/10.2147/COPD.S419846.

APA

Ellis, P., Bailey, E., Choate, R., Holm, K. E., Sandhaus, R. A., Turner, A. M., & Newnham, M. (2024). Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD. International Journal of COPD, 19, 149–159. https://doi.org/10.2147/COPD.S419846

Chicago

Ellis, Paul, Emily Bailey, Radmila Choate, Kristen E Holm, Robert A Sandhaus, Alice M Turner, and Michael Newnham. 2024. “Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD.” International Journal of COPD 19 (January): 149–59. doi:10.2147/COPD.S419846.